Chinese Society of Clinical Oncology 2026
Interviews and expert commentary from Chinese Society of Clinical Oncology 2026 — study authors and key opinion leaders discuss the findings and their clinical implications.
Fang Wu MD PhD; CSCO 2026: Could Emotional Distress Medicines Prolong Survival in Patients with Small Cell Lung Cancer?
JINAN, China—Provocative evidence is emerging that emotional distress can adversely affect outcomes among patients with lung cancer. Data from a study of the role of hormones in affecting lung cancer outcomes were reported at the 2026 Annual Meeting of the Chinese Society of Clinical Oncology in an oral communication entitled: Clinical Impact of Baseline Hormones on Outcomes of First Line Immunotherapy in Extensive Stage Small-Cell Lung Cancer. Peter Goodwin discussed the findings with first author Fang Wu MD PhD, Deputy Director, Chief Physician, Professor and Doctoral Supervisor in the Department of Oncology at the Second Xiangya Hospital Cancer Center in Central South University, Changsha, China.